Transcranial photobiomodulation for neurodevelopmental disorders: a narrative review
- 15 July 2024
- journal article
- review article
- Published by Springer Nature in Photochemical & Photobiological Sciences
- Vol. 23 (8) , 1609-1623
Abstract
Background Neurodevelopmental disorders (NDDs) such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and Down syndrome (DS) significantly impact social, communicative, and behavioral functioning. Transcranial photobiomodulation (t-PBM) with near-infrared light is a promising non-invasive neurostimulation technique for neuropsychiatric disorders, including NDDs. This narrative review aimed to examine the preclinical and clinical evidence of photobiomodulation (PBM) in treating NDDs. Methods A comprehensive search across six databases was conducted, using a combination of MeSH terms and title/abstract keywords: “photobiomodulation”, “PBM”, “neurodevelopmental disorders”, “NDD”, and others. Studies applying PBM to diagnosed NDD cases or animal models replicating NDDs were included. Protocols, reviews, studies published in languages other than English, and studies not evaluating clinical or cognitive outcomes were excluded. Results Nine studies were identified, including one preclinical and eight clinical studies (five on ASD, two on ADHD, and one on DS). The reviewed studies encompassed various t-PBM parameters (wavelengths: 635–905 nm) and targeted primarily frontal cortex areas. t-PBM showed efficacy in improving disruptive behavior, social communication, cognitive rigidity, sleep quality, and attention in ASD; in enhancing attention in ADHD; and in improving motor skills and verbal fluency in DS. Minimal adverse effects were reported. Proposed mechanisms involve enhanced mitochondrial function, modulated oxidative stress, and reduced neuroinflammation. Conclusions t-PBM emerges as a promising intervention for NDDs, with potential therapeutic effects across ASD, ADHD, and DS. These findings underscore the need for further research, including larger-scale, randomized sham-controlled clinical trials with comprehensive biomarker analyses, to optimize treatment parameters and understand the underlying mechanisms associated with the effects of t-PBM. Graphical abstractKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2021/10982-1, 2019/21158-8)
This publication has 113 references indexed in Scilit:
- Inflammation in obsessive–compulsive disorder: A literature review and hypothesis‐based potential of transcranial photobiomodulationJournal of Neuroscience Research, 2024
- Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults With Attention-Deficit/Hyperactivity DisorderJAMA Psychiatry, 2022
- Individual and Combined Association Between Prenatal Polysubstance Exposure and Childhood Risk of Attention-Deficit/Hyperactivity DisorderJAMA Network Open, 2022
- Effect of Transcranial Low-Level Light Therapy vs Sham Therapy Among Patients With Moderate Traumatic Brain InjuryJAMA Network Open, 2020
- Differences in brain networks of children with ADHD: Whole‐brain analysis of resting‐state fMRIInternational Journal of Imaging Systems and Technology, 2019
- Transient states of network connectivity are atypical in autism: A dynamic functional connectivity studyHuman Brain Mapping, 2019
- Transcranial laser stimulation improves human cerebral oxygenationLasers in Surgery and Medicine, 2016
- Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United StatesAmerican Journal of Medical Genetics Part A, 2015
- Similarity of Lateralized Rhythmic Delta Activity to Periodic Lateralized Epileptiform Discharges in Critically Ill PatientsJAMA Neurology, 2013
- Psychiatric and behavioral disorders in persons with Down syndromeMental Retardation and Developmental Disabilities Research Reviews, 2007